1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Acne Vulgaris Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 CB-0601
  • 1.2.3 CJM-112
  • 1.2.4 CLS-007
  • 1.2.5 Dapsone
  • 1.2.6 DFD-10
  • 1.2.7 DLX-2323
  • 1.2.8 Others
• 1.3 Market by Application
  • 1.3.1 Global Acne Vulgaris Treatment Market Share by Application: 2020 VS 2026
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Acne Vulgaris Treatment Market Perspective (2015-2026)
• 2.2 Global Acne Vulgaris Treatment Growth Trends by Regions
  • 2.2.1 Acne Vulgaris Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Acne Vulgaris Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Acne Vulgaris Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Acne Vulgaris Treatment Players by Market Size
  • 3.1.1 Global Top Acne Vulgaris Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Acne Vulgaris Treatment Revenue Market Share by Players (2015-2020)
• 3.2 Global Acne Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Acne Vulgaris Treatment Revenue
• 3.4 Global Acne Vulgaris Treatment Market Concentration Ratio
  • 3.4.1 Global Acne Vulgaris Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Acne Vulgaris Treatment Revenue in 2019
• 3.5 Key Players Acne Vulgaris Treatment Area Served
• 3.6 Key Players Acne Vulgaris Treatment Product Solution and Service
• 3.7 Date of Enter into Acne Vulgaris Treatment Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Acne Vulgaris Treatment Breakdown Data by Type (2015-2026)

• 4.1 Global Acne Vulgaris Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Acne Vulgaris Treatment Forecasted Market Size by Type (2021-2026)

5 Acne Vulgaris Treatment Breakdown Data by Application (2015-2026)

• 5.1 Global Acne Vulgaris Treatment Historic Market Size by Application (2015-2020)
• 5.2 Global Acne Vulgaris Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Acne Vulgaris Treatment Market Size (2015-2026)
• 6.2 North America Acne Vulgaris Treatment Market Size by Type (2015-2020)
• 6.3 North America Acne Vulgaris Treatment Market Size by Application (2015-2020)
• 6.4 North America Acne Vulgaris Treatment Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Acne Vulgaris Treatment Market Size (2015-2026)
• 7.2 Europe Acne Vulgaris Treatment Market Size by Type (2015-2020)
• 7.3 Europe Acne Vulgaris Treatment Market Size by Application (2015-2020)
• 7.4 Europe Acne Vulgaris Treatment Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Acne Vulgaris Treatment Market Size (2015-2026)
• 8.2 China Acne Vulgaris Treatment Market Size by Type (2015-2020)
• 8.3 China Acne Vulgaris Treatment Market Size by Application (2015-2020)
• 8.4 China Acne Vulgaris Treatment Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Acne Vulgaris Treatment Market Size (2015-2026)
• 9.2 Japan Acne Vulgaris Treatment Market Size by Type (2015-2020)
• 9.3 Japan Acne Vulgaris Treatment Market Size by Application (2015-2020)
• 9.4 Japan Acne Vulgaris Treatment Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Acne Vulgaris Treatment Market Size (2015-2026)
• 10.2 Southeast Asia Acne Vulgaris Treatment Market Size by Type (2015-2020)
• 10.3 Southeast Asia Acne Vulgaris Treatment Market Size by Application (2015-2020)
• 10.4 Southeast Asia Acne Vulgaris Treatment Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Common Pharma Inc
  • 11.1.1 Common Pharma Inc Company Details
  • 11.1.2 Common Pharma Inc Business Overview
  • 11.1.3 Common Pharma Inc Acne Vulgaris Treatment Introduction
  • 11.1.4 Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2015-2020))
  • 11.1.5 Common Pharma Inc Recent Development
• 11.2 Cutanea Life Sciences Inc
  • 11.2.1 Cutanea Life Sciences Inc Company Details
  • 11.2.2 Cutanea Life Sciences Inc Business Overview
  • 11.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Introduction
  • 11.2.4 Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 11.2.5 Cutanea Life Sciences Inc Recent Development
• 11.3 Dermira Inc
  • 11.3.1 Dermira Inc Company Details
  • 11.3.2 Dermira Inc Business Overview
  • 11.3.3 Dermira Inc Acne Vulgaris Treatment Introduction
  • 11.3.4 Dermira Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 11.3.5 Dermira Inc Recent Development
• 11.4 ELORAC Inc
  • 11.4.1 ELORAC Inc Company Details
  • 11.4.2 ELORAC Inc Business Overview
  • 11.4.3 ELORAC Inc Acne Vulgaris Treatment Introduction
  • 11.4.4 ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 11.4.5 ELORAC Inc Recent Development
• 11.5 Ensol Biosciences Inc
  • 11.5.1 Ensol Biosciences Inc Company Details
  • 11.5.2 Ensol Biosciences Inc Business Overview
  • 11.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Introduction
  • 11.5.4 Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 11.5.5 Ensol Biosciences Inc Recent Development
• 11.6 Foamix Pharmaceuticals Ltd
  • 11.6.1 Foamix Pharmaceuticals Ltd Company Details
  • 11.6.2 Foamix Pharmaceuticals Ltd Business Overview
  • 11.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Introduction
  • 11.6.4 Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 11.6.5 Foamix Pharmaceuticals Ltd Recent Development
• 11.7 Galderma SA
  • 11.7.1 Galderma SA Company Details
  • 11.7.2 Galderma SA Business Overview
  • 11.7.3 Galderma SA Acne Vulgaris Treatment Introduction
  • 11.7.4 Galderma SA Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 11.7.5 Galderma SA Recent Development
• 11.8 GlaxoSmithKline Plc
  • 11.8.1 GlaxoSmithKline Plc Company Details
  • 11.8.2 GlaxoSmithKline Plc Business Overview
  • 11.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Introduction
  • 11.8.4 GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 11.8.5 GlaxoSmithKline Plc Recent Development
• 11.9 Helix BioMedix Inc
  • 11.9.1 Helix BioMedix Inc Company Details
  • 11.9.2 Helix BioMedix Inc Business Overview
  • 11.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Introduction
  • 11.9.4 Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 11.9.5 Helix BioMedix Inc Recent Development
• 11.10 Hovione FarmaCiencia SA
  • 11.10.1 Hovione FarmaCiencia SA Company Details
  • 11.10.2 Hovione FarmaCiencia SA Business Overview
  • 11.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Introduction
  • 11.10.4 Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 11.10.5 Hovione FarmaCiencia SA Recent Development
• 11.11 Lee's Pharmaceutical Holdings Ltd
  • 10.11.1 Lee's Pharmaceutical Holdings Ltd Company Details
  • 10.11.2 Lee's Pharmaceutical Holdings Ltd Business Overview
  • 10.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Introduction
  • 10.11.4 Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.11.5 Lee's Pharmaceutical Holdings Ltd Recent Development
• 11.12 LEO Pharma A/S
  • 10.12.1 LEO Pharma A/S Company Details
  • 10.12.2 LEO Pharma A/S Business Overview
  • 10.12.3 LEO Pharma A/S Acne Vulgaris Treatment Introduction
  • 10.12.4 LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.12.5 LEO Pharma A/S Recent Development
• 11.13 Novabiotics Ltd
  • 10.13.1 Novabiotics Ltd Company Details
  • 10.13.2 Novabiotics Ltd Business Overview
  • 10.13.3 Novabiotics Ltd Acne Vulgaris Treatment Introduction
  • 10.13.4 Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.13.5 Novabiotics Ltd Recent Development
• 11.14 Novan Inc
  • 10.14.1 Novan Inc Company Details
  • 10.14.2 Novan Inc Business Overview
  • 10.14.3 Novan Inc Acne Vulgaris Treatment Introduction
  • 10.14.4 Novan Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.14.5 Novan Inc Recent Development
• 11.15 Novartis AG
  • 10.15.1 Novartis AG Company Details
  • 10.15.2 Novartis AG Business Overview
  • 10.15.3 Novartis AG Acne Vulgaris Treatment Introduction
  • 10.15.4 Novartis AG Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.15.5 Novartis AG Recent Development
• 11.16 Paratek Pharmaceuticals Inc
  • 10.16.1 Paratek Pharmaceuticals Inc Company Details
  • 10.16.2 Paratek Pharmaceuticals Inc Business Overview
  • 10.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Introduction
  • 10.16.4 Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.16.5 Paratek Pharmaceuticals Inc Recent Development
• 11.17 Pfizer Inc
  • 10.17.1 Pfizer Inc Company Details
  • 10.17.2 Pfizer Inc Business Overview
  • 10.17.3 Pfizer Inc Acne Vulgaris Treatment Introduction
  • 10.17.4 Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.17.5 Pfizer Inc Recent Development
• 11.18 Phosphagenics Ltd
  • 10.18.1 Phosphagenics Ltd Company Details
  • 10.18.2 Phosphagenics Ltd Business Overview
  • 10.18.3 Phosphagenics Ltd Acne Vulgaris Treatment Introduction
  • 10.18.4 Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.18.5 Phosphagenics Ltd Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Acne Vulgaris Treatment Scope and Market Size
Acne Vulgaris Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acne Vulgaris Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
CB-0601
CJM-112
CLS-007
Dapsone
DFD-10
DLX-2323
Others

Market segment by Application, split into
Clinic
Hospital
Others

Based on regional and country-level analysis, the Acne Vulgaris Treatment market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Acne Vulgaris Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Common Pharma Inc
Cutanea Life Sciences Inc
Dermira Inc
ELORAC Inc
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline Plc
Helix BioMedix Inc
Hovione FarmaCiencia SA
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
Novabiotics Ltd
Novan Inc
Novartis AG
Paratek Pharmaceuticals Inc
Pfizer Inc
Phosphagenics Ltd